logo
Share SHARE
FONT-SIZE Plus   Neg

AngioDynamics Receives FDA Clearance For BioFlo PICCs With Endexo Technology

AngioDynamics Inc. (ANGO) announced the U.S. Food and Drug Administration has granted 510(k) clearance for its BioFlo peripherally inserted central catheters or PICCs with Endexo technology designed to reduce the accumulation of catheter-related thrombus on, and in, the catheter.

It is expected to launch in the second quarter of fiscal year 2013. These products are currently CE marked for Europe and are approved in Canada and other international markets.

"We expect to launch BioFlo technology with PASV PICCs in the U.S. within the next 30 days," said Chuck Greiner, Vice President of the Global Vascular Access Franchise.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Continuing efforts to normalize relations, President Barack Obama announced Wednesday the U.S. and Cuba will re-open embassies in each country's respective capitals later this month. Obama described the move as a demonstration that the U.S. and Cuba don't have to be imprisoned by the past. For pragmatic reasons, Senator Lindsay Graham no longer wants the party to "reaffirm our support for a Constitutional amendment defining marriage as the union of one man and one woman," as they did at the 2012 Republican Convention. The most "American" vehicle isn't Built Ford Tough. It's not in jingles sung by John Mellencamp or Bob Seger, and it probably isn't kickin' up backroads dust somewhere in the Heartland.
comments powered by Disqus
RELATED NEWS
Trade ANGO now with 
Follow RTT